Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.64 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.57882 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.76757 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.1493 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.7719 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.02739 | 84 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.85043 | 83 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.97194 | 82 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.60513 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.61793 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.43364 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.65646 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.70102 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.4502 | 79 |